These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. The implantation of sepharose beads in mouse livers as an aid in the study of hepatic schistosomal fibrosis. van Marck EA; Stocker S; Grimaud JA; Kestens L; Gigase PL; Deelder AM Experientia; 1980 Sep; 36(9):1116-8. PubMed ID: 7191376 [TBL] [Abstract][Full Text] [Related]
49. Portal pressure response to propranolol in portal hypertension. Ozsoylu S; Koçak N; Yüce A; Ozbag E J Hepatol; 1992 May; 15(1-2):270-1. PubMed ID: 1506652 [No Abstract] [Full Text] [Related]
50. Colchicine therapy for hepatic murine schistosomal fibrosis: image analysis and serological study. Badawy AA; el-Badrawy NM; Hassan MM; Ebeid FA Int J Exp Pathol; 1999 Feb; 80(1):25-34. PubMed ID: 10365084 [TBL] [Abstract][Full Text] [Related]
52. Propranolol for portal hypertension. Dominguez P Lancet; 1981 Jun; 1(8233):1322-3. PubMed ID: 6112641 [No Abstract] [Full Text] [Related]
53. Thrombocytemia as a predictor of portal hypertension in schistosomiasis. Souza MR; Toledo CF; Borges DR Dig Dis Sci; 2000 Oct; 45(10):1964-70. PubMed ID: 11117568 [TBL] [Abstract][Full Text] [Related]
54. Chronic murine hepatosplenic schistosomiasis mansoni: relative irreversibility after treatment. Warren KS; Klein L Trans R Soc Trop Med Hyg; 1969; 63(3):333-7. PubMed ID: 4307556 [No Abstract] [Full Text] [Related]
55. Effect of propranolol on renal blood flow in portal hypertensive rats. Cales P; Braillon A; Girod C; Lebrec D Gastroenterology; 1985 Mar; 88(3):857. PubMed ID: 3967812 [No Abstract] [Full Text] [Related]
56. Risk of hepatic encephalopathy in patients taking propranolol for portal hypertension. Reding P Lancet; 1982 Sep; 2(8297):550. PubMed ID: 6125697 [No Abstract] [Full Text] [Related]